Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,616
Award facts
- Contract value 100% obligated
- $43,615.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,615.60 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on December 19, 2025, with completion targeted for December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's contract portfolio with DLA demonstrates extensive capability in delivering brand-name and generic medications across multiple therapeutic domains, from specialty diabetes treatments to neurological and pain management pharmaceuticals. This delivery order for Zepbound reflects AmerisourceBergen's role in supplying pharmaceutical products essential to military healthcare programs, with the underlying IDC enabling flexible fulfillment of medical supply requirements across global operations.
Quick answers
Who was awarded contract SPE2DR26F9R53?
SPE2DR26F9R53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9R53 worth?
The government has obligated $43,616 on SPE2DR26F9R53.
Is contract SPE2DR26F9R53 an order under another contract?
Yes. SPE2DR26F9R53 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9R53 competed?
The extent of competition for SPE2DR26F9R53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award